Literature DB >> 3907626

The selectivity of action of the aspartic-proteinase inhibitor IA3 from yeast (Saccharomyces cerevisiae).

T Dreyer, M J Valler, J Kay, P Charlton, B M Dunn.   

Abstract

The ability of the aspartic-proteinase inhibitor IA3 from yeast (Saccharomyces cerevisiae) to affect the activities of a range of mammalian and microbial aspartic proteinases was examined. The inhibitor appeared to be completely selective in that only the aspartic proteinase A from yeast was inhibited to any significant extent. IA3 thus represents the first example of a totally specific, naturally occurring, aspartic-proteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3907626      PMCID: PMC1152817          DOI: 10.1042/bj2310777

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Interaction of human cathepsin D with the inhibitor pepstatin.

Authors:  C G Knight; A J Barrett
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

2.  Studies on the proteinase-A inhibitor I3A from yeast.

Authors:  I Núñez de Castro; H Holzer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-05

3.  Urification and characterization of macromolecular inhibitors of proteinase A from yeast.

Authors:  T Saheki; Y Matsuda; H Holzer
Journal:  Eur J Biochem       Date:  1974-09-01

4.  Pepsin inhibitors from Ascaris lumbricoides. Pepsin-inhibitor complex: stoichiometry of formation, dissociation, and stability of the complex.

Authors:  G M Abu-Erreish; R J Peanasky
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

5.  Potent new inhibitors of human renin.

Authors:  M Szelke; B Leckie; A Hallett; D M Jones; J Sueiras; B Atrash; A F Lever
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

6.  Effect of pepstatin on acid proteases.

Authors:  T Aoyagi; S Kunimoto; H Morishima; T Takeuchi; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1971-10       Impact factor: 2.649

7.  The active site of aspartic proteinases.

Authors:  L Pearl; T Blundell
Journal:  FEBS Lett       Date:  1984-08-20       Impact factor: 4.124

8.  The effects of lactoyl-pepstatin and the pepsin inhibitor peptide on pig cathepsin D.

Authors:  J Kay; E G Afting; T Aoyagi; B M Dunn
Journal:  Biochem J       Date:  1982-06-01       Impact factor: 3.857

9.  Inhibition of pepsin by analogues of pepsinogen-(1-12)-peptide with substitutions in the 4-7 sequence region.

Authors:  B M Dunn; M Lewitt; C Pham
Journal:  Biochem J       Date:  1983-02-01       Impact factor: 3.857

10.  A 56,000-dalton renin-binding protein in hog kidney is an endogenous renin inhibitor.

Authors:  N Ueno; H Miyazaki; S Hirose; K Murakami
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

View more
  5 in total

1.  Predicting functional residues of the Solanum lycopersicum aspartic protease inhibitor (SLAPI) by combining sequence and structural analysis with molecular docking.

Authors:  Yasel Guerra; Pedro A Valiente; Colin Berry; Tirso Pons
Journal:  J Mol Model       Date:  2011-11-20       Impact factor: 1.810

2.  Test and Evaluation of ff99IDPs Force Field for Intrinsically Disordered Proteins.

Authors:  Wei Ye; Dingjue Ji; Wei Wang; Ray Luo; Hai-Feng Chen
Journal:  J Chem Inf Model       Date:  2015-05-13       Impact factor: 4.956

3.  A systematic series of synthetic chromophoric substrates for aspartic proteinases.

Authors:  B M Dunn; M Jimenez; B F Parten; M J Valler; C E Rolph; J Kay
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

4.  Aspartic proteinase from barley grains is related to mammalian lysosomal cathepsin D.

Authors:  P Sarkkinen; N Kalkkinen; C Tilgmann; J Siuro; J Kervinen; L Mikola
Journal:  Planta       Date:  1992-02       Impact factor: 4.116

5.  Multi-scaled explorations of binding-induced folding of intrinsically disordered protein inhibitor IA3 to its target enzyme.

Authors:  Jin Wang; Yong Wang; Xiakun Chu; Stephen J Hagen; Wei Han; Erkang Wang
Journal:  PLoS Comput Biol       Date:  2011-04-07       Impact factor: 4.475

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.